Allison C, Page H, George S
Department of Public Health Medicine, University of Sheffield Medical School.
J Epidemiol Community Health. 1994 Apr;48(2):178-81. doi: 10.1136/jech.48.2.178.
To investigate the current and likely future provision of screening services for risk factors for coronary heart disease in retail pharmacies in Sheffield.
This was a questionnaire survey asking about screening tests currently offered, price charged per test, likely future provision of screening tests, the action respondents would take upon finding an abnormal test result, whether the pharmacy was owner-run, franchised, or part of a commercial chain, and inviting open comments from respondents.
All retail pharmacy premises on the Sheffield Family Health Services Authority list.
Seventy seven responses were obtained to 102 questionnaires distributed. Only nine of these currently offered any screening test other than pregnancy testing, although 37 indicated that they might offer tests in the future. Thirty nine were not offering screening and had no plans to do so. Pharmacies offering or likely to offer screening tests were mainly owner-run. All pharmacists who replied to the question asking about their action upon finding abnormal result (33) reported that they would advise the patient to see a doctor. The most frequent comments made by pharmacists were about the commercial viability of screening in pharmacies and the lack of space available to ensure patient privacy and confidentiality during screening.
Screening in retail pharmacies would probably be a commercial failure unless doctors were able to contract for screening services from pharmacies. Evidence from this study and others, however, leads us to question the desirability of this option.
调查谢菲尔德市零售药店目前以及未来可能提供的冠心病风险因素筛查服务情况。
这是一项问卷调查,询问了当前提供的筛查测试、每项测试的收费价格、未来可能提供的筛查测试、受访者在发现测试结果异常时会采取的行动、药店是自营、特许经营还是商业连锁的一部分,并邀请受访者发表公开意见。
谢菲尔德家庭健康服务管理局名单上的所有零售药店。
在分发的102份问卷中获得了77份回复。目前,这些药店中只有9家提供除妊娠测试以外的任何筛查测试,不过有37家表示未来可能会提供测试。39家药店未提供筛查服务且没有这样做的计划。提供或可能提供筛查测试的药店主要是自营的。所有回答了关于发现异常结果时会采取何种行动这一问题的药剂师(33人)均表示,他们会建议患者去看医生。药剂师最常提到的意见是关于药店筛查的商业可行性以及在筛查期间缺乏确保患者隐私和保密的空间。
除非医生能够与药店签订筛查服务合同,否则零售药店的筛查可能会在商业上失败。然而,这项研究和其他研究的证据让我们对这一选择的可取性产生了质疑。